Live Quote · NASDAQRNACHealthcare· Biotechnology

Cartesian Therapeutics, Inc.

$6.14▲ 4.24%(+$0.25)
MKT CAP $187.29MNEXT EARNINGS Mar 8, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
60
Valuation
60
Profitability
10
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RNAC research report →

Analyst Price Target
$20.50+233.9% vs. today

Range $16 – $25

Analyst RatingBuy
8 Buy2 Hold0 Sell

Price Chart

-17.62% · this period
$10.59$8.21$5.84Nov 19May 22Nov 19
52-Week Range10% of range
Low
$5.60
Current
$6.14
High
$11.00